IGM Biosciences

+$0.69 (+4.41%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGMS and other ETFs, options, and stocks.

About IGMS

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies.

CEO
Fred M. Schwarzer
Employees
192
Headquarters
Mountain View, California
Founded
2010

IGMS Key Statistics

Market cap
552.12M
Price-Earnings ratio
—
Dividend yield
—
Average volume
457.37K
High today
$16.56
Low today
$15.32
Open price
$15.61
Volume
367.43K
52 Week high
$99.44
52 Week low
$12.74

IGMS Earnings

-$1.61
-$1.07
-$0.54
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure